M. Thomas

Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs.

W. Seeger, F. Grimminger, I. Holland, 1991, The American review of respiratory disease.

Inflammatory lipid mediator generation elicited by viable hemolysin- forming Escherichia coli in lung vasculature

W. Seeger, F. Grimminger, S. Bhakdi, 1990, The Journal of experimental medicine.

Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia

N. Loman, L. Wooldridge, D. Altmann, 2020, medRxiv.

Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.

C. Natanson, S. Banks, R. Danner, 1997, The Journal of clinical investigation.